In the present study, we used multiple gene screening of 320 NSCLC patients harboring EGFR-sensitive mutations and evaluated the frequency of concomitant genetic alterations, further to investigate the efficacy of EGFR-TKIs treatment in these patients. Here, EGFR is linked to non-small cell lung carcinoma.